ZENIT
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ZENIT Trademark

Serial Number: 79193284 • Registration: 5326360

ZENIT is a trademark filed by A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l. on June 7, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l. (25 trademarks)

Via dei Sette Santi No.3
50131 FIRENZE , IT

Entity Type: 03

Trademark Details

Filing Date

June 7, 2016

Registration Date

November 7, 2017

Published for Opposition

August 22, 2017

Cancellation Date

May 24, 2024

Goods & Services

Diagnostic apparatus for laboratory or research use for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates; diagnostic equipment for scientific or laboratory use, namely, for detecting antibodies; diagnostic apparatus for the detection of antibodies for laboratory or scientific research use; diagnostic equipment for scientific or laboratory use, namely, microplate and glass slide processors; diagnostic equipment for scientific or laboratory use, namely, microplate readers; diagnostic equipment for scientific or laboratory use, namely, plates, glass slides and chips having multi-well arrays that can be used in chemical analysis and biological analysis for patterning; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates, the diagnostic apparatus having as an integral component, preloaded software that enables image capture and storage, immunofluorescence detection, pattern recognition, and automated analysis; diagnostic equipment for scientific or laboratory use for detecting antibodies, the diagnostic equipment having as an integral component, preloaded software for automating enzyme linked immunosorbent assay, immunofluorescence assay and microarray methods; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates, the diagnostic apparatus having as an integral component, preloaded software for the detection of antibodies for laboratory or research use; diagnostic equipment for scientific or laboratory use, namely, microplate processors and glass slide processors, the diagnostic equipment having as an integral component, preloaded software for automating enzyme linked immunosorbent assay, immunofluorescence assay and microarray methods

Medical apparatus for automatically diagnosing, reading and interpreting specimens by indirect immunofluorescence on cell substrates; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes; medical apparatus for automatically diagnosing, reading and interpreting specimens by indirect immunofluorescence on cell substrates, the medical apparatus having as an integral component, preloaded software that enables image capture and storage, immunofluorescence detection, pattern recognition, and automated analysis; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases, the medical diagnostic apparatus having as an integral component, preloaded software for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids, the medical diagnostic instruments having as an integral component, preloaded software for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes, the immunological analyzers having as an integral component preloaded software for detecting immune system components; hematology analyzers for medical diagnostic purposes, the hematology analyzers having as an integral component preloaded software for blood cell analysis

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
May 31, 2025 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Mar 29, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 29, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 24, 2025 INTR
CANCELLED SECTION 71
May 24, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 13, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 14, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 14, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 7, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 22, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 22, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Aug 18, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 14, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 14, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 14, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 14, 2017 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 7, 2017 TCCA
FINAL REFUSAL MAILED
May 3, 2017 CNFR
FINAL REFUSAL WRITTEN
May 3, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 25, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 9, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 9, 2016 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 18, 2016 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 16, 2016 RFCR
NON-FINAL ACTION WRITTEN
Oct 15, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 12, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 6, 2016 REPR